These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25927321)

  • 1. Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study.
    Pascual S; Feimer J; De Soyza A; Sauleda Roig J; Haughney J; Padullés L; Seoane B; Rekeda L; Ribera A; Chrystyn H
    NPJ Prim Care Respir Med; 2015 Apr; 25():15018. PubMed ID: 25927321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference, satisfaction and errors with two dry powder inhalers in patients with COPD.
    van der Palen J; Ginko T; Kroker A; van der Valk P; Goosens M; Padullés L; Seoane B; Rekeda L; Garcia Gil E
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1023-31. PubMed ID: 23745954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.
    Man KN; Tian Z; Lam DC; Wan JMF; Tan-Un KC
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1949-1963. PubMed ID: 29942127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the preference, satisfaction and correct use of Breezhaler
    Oliveira MVC; Pizzichini E; da Costa CH; Fritscher CC; Vianna EO; Teixeira PJZ; Stirbulov R; Rabahi MF; Pinho NC
    Respir Med; 2018 Nov; 144():61-67. PubMed ID: 30366585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey.
    Price D; Keininger DL; Viswanad B; Gasser M; Walda S; Gutzwiller FS
    Int J Chron Obstruct Pulmon Dis; 2018; 13():695-702. PubMed ID: 29520137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices.
    van der Palen J; Thomas M; Chrystyn H; Sharma RK; van der Valk PD; Goosens M; Wilkinson T; Stonham C; Chauhan AJ; Imber V; Zhu CQ; Svedsater H; Barnes NC
    NPJ Prim Care Respir Med; 2016 Nov; 26():16079. PubMed ID: 27883002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferences and Inhalation Techniques for Inhaler Devices Used by Patients with Chronic Obstructive Pulmonary Disease.
    Bournival R; Coutu R; Goettel N; Yang CD; Cantin-Lafleur A; Lemieux C; Lévesque AM; Patenaude-Monette JF; Roy FO; Blais L; Arbour F; Fillion A; Beauchesne MF
    J Aerosol Med Pulm Drug Deliv; 2018 Aug; 31(4):237-247. PubMed ID: 29206566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD.
    Miravitlles M; Montero-Caballero J; Richard F; Santos S; Garcia-Rivero JL; Ortega F; Ribera X
    Int J Chron Obstruct Pulmon Dis; 2016; 11():407-15. PubMed ID: 27013871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Inhaler Satisfaction and Determinants of High Satisfaction Among Korean COPD Patients.
    Jang JG; Lee KH; Chung JH; Shin KC; Choi EY; Jin HJ; Ahn JH
    J Korean Med Sci; 2022 Nov; 37(46):e327. PubMed ID: 36631025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients.
    Jang JG; Chung JH; Shin KC; Jin HJ; Lee KH; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1051-1059. PubMed ID: 33907392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry-powder inhalers in patients with persistent airflow limitation: usability and preference.
    Dal Negro RW; Povero M
    Multidiscip Respir Med; 2016; 11(1):31. PubMed ID: 27597888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD.
    Magnussen H; Watz H; Zimmermann I; Macht S; Greguletz R; Falques M; Jarreta D; Garcia Gil E
    Respir Med; 2009 Dec; 103(12):1832-7. PubMed ID: 19651504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, cross-over study comparing critical and overall errors, learning time, and preference of the ELLIPTA versus BREEZHALER dry powder inhalers in patients with asthma.
    van der Palen J; Slade D; Rehal S; Verma M; Plank M
    Respir Med; 2022 Dec; 205():107031. PubMed ID: 36368290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical simulation of the effect of inhalation parameters, gender, age and disease severity on the lung deposition of dry powder aerosol drugs emitted by Turbuhaler®, Breezhaler® and Genuair® in COPD patients.
    Horváth A; Farkas Á; Szipőcs A; Tomisa G; Szalai Z; Gálffy G
    Eur J Pharm Sci; 2020 Nov; 154():105508. PubMed ID: 32836137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.
    García-Río F; Soler-Cataluña JJ; Alcazar B; Viejo JL; Miravitlles M
    COPD; 2017 Dec; 14(6):573-580. PubMed ID: 28891722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Preference Study of Two Placebo Dry Powder Inhalers in Adults with COPD: ELLIPTA® Dry Powder Inhaler (DPI) versus DISKUS® DPI.
    Yun Kirby S; Zhu CQ; Kerwin EM; Stanford RH; Georges G
    COPD; 2016; 13(2):167-75. PubMed ID: 26516724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
    Komase Y; Asako A; Kobayashi A; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD.
    Chrystyn H; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Respir Med; 2014 Feb; 108(2):358-65. PubMed ID: 24209768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, open-label, single-visit, crossover study simulating triple-drug delivery with Ellipta compared with dual inhaler combinations in patients with COPD.
    van der Palen J; Moeskops-van Beurden W; Dawson CM; James WY; Preece A; Midwinter D; Barnes N; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2515-2523. PubMed ID: 30174421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.